home / stock / mynd:cc / mynd:cc news


MYND:CC News and Press, Mynd Life Sciences Inc.

Stock Information

Company Name: Mynd Life Sciences Inc.
Stock Symbol: MYND:CC
Market: CNQC
Website: myndsciences.com

Menu

MYND:CC MYND:CC Quote MYND:CC Short MYND:CC News MYND:CC Articles MYND:CC Message Board
Get MYND:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

MYND:CC - Canadian Companies Moving the Markets, Evening edition
Thu, Jun 27, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada BlackBerry Limited (BB) rose 10.5% to $3.36 on volume of 12,209,225 shares Solstice Gold Corp. (SGC) fell 33.3% to $0.02 on volume of 11,588,936 shares HIGH INTEREST SAVINGS ACCOUNT FUND (HISA) fell 0.3% to $50.01 on volume of 10,628,355 shares ...

MYND:CC - Canadian Companies Moving the Markets, Morning edition
Wed, Apr 17, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada BMO Long Federal Bond Index ETF (ZFL) rose 0.2% to $12.35 on volume of 10,056,021 shares Delta 9 Cannabis Inc. (DN) fell 16.7% to $0.025 on volume of 6,264,289 shares BMO Equal Weight Banks Index ETF (ZEB) rose 0.7% to $35.61 on volume of 4,183,...

MYND:CC - Canadian Companies Moving the Markets, Evening edition
Thu, Mar 14, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada Suncor Energy Inc. (SU) rose 1.9% to $48.81 on volume of 19,956,265 shares Canadian Natural Resources Limited (CNQ) rose 0.0% to $99.61 on volume of 19,560,678 shares Lundin Mining Corporation (LUN) rose 1.7% to $12.92 on volume of 16,584,382 sh...

MYND:CC - MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company ") The Company is pleased to welcome Ms. Laurie Bakke who was recently appointed to MYND's Board. Ms. Bakke joins as an independent non-executive director,...

MYND:CC - MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences  (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a pioneering biopharmaceutical research and development company committed to advancing treatments for patients coping with chronic and a...

MYND:CC - Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - MYND Life Sciences  (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), We are delighted to announce the appointment of Mynd Life Sciences current CEO and Director, the Hon. Dr. Lyle Oberg, E.C.A., as the Boa...

MYND:CC - MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.

Potential merger to create new industry leader. Vancouver, British Columbia--(Newsfile Corp. - October 25, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a pioneering biopharmaceutical research and development company dedicated to revolutionizing treatment...

MYND:CC - MYND Life Sciences Announces Update on Payment Obligations Under Unsecured Convertible Debentures

MYND Life Sciences was formed to commercialize proprietary biomarker diagnostic tests and novel therapeutics for patients suffering from MDD, TRD and other neuro-inflammatory disorders Vancouver, British Columbia--(Newsfile Corp. - September 11, 2023) - MYND Life Sciences Inc. (CSE: MYND) (OTCQ...

MYND:CC - MYND Life Sciences Inc. Has Management CTO Revoked

Vancouver, British Columbia--(Newsfile Corp. - May 9, 2023) - MYND Life Sciences  ( CSE: MYND ) ( OTCQB: MYNDF ) (" MYND " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological di...

MYND:CC - MYND Life Sciences Inc. Provides Default Status Report

Vancouver, British Columbia--(Newsfile Corp. - April 12, 2023) - MYND Life Sciences  (CSE:  MYND ) (OTCQB:  MYNDF ) (" MYND " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological...

Next 10